America February 23, 2026
Gilead to Acquire Arcellx in $7.8B Biotech Bet on Cancer Therapy
In a high-stakes move that could reshape the cancer treatment landscape, Gilead to acquire Arcellx became the headline Monday as…
America February 23, 2026
In a high-stakes move that could reshape the cancer treatment landscape, Gilead to acquire Arcellx became the headline Monday as…
By Rihem Akkouche